State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.

dc.contributor.author

Mantri, Sneha

dc.contributor.author

Fullard, Michelle E

dc.contributor.author

Beck, James

dc.contributor.author

Willis, Allison W

dc.date.accessioned

2019-07-01T13:26:12Z

dc.date.available

2019-07-01T13:26:12Z

dc.date.issued

2019-01-24

dc.date.updated

2019-07-01T13:26:11Z

dc.description.abstract

State-level variations in disease, healthcare utilization, and spending influence healthcare planning at federal and state levels and should be examined to understand national disparities in health outcomes. This descriptive study examined state-level variations in Parkinson disease (PD) prevalence, patient characteristics, Medicare spending, out-of-pocket costs, and health service utilization using data on 27.5 million Medicare beneficiaries in the US in 2014. We found that 45.8% (nā€‰=ā€‰179,496) of Medicare beneficiaries diagnosed with PD were women; 26.1% (nā€‰=ā€‰102,205) were aged 85+. The District of Columbia, New York, Illinois, Connecticut, and Florida had the highest age-, race-, and sex-adjusted prevalence of Parkinson disease among Medicare beneficiaries in the US. Women comprised over 48.5% of PD patient populations in West Virginia, Kentucky, Mississippi, Louisiana, and Arkansas. More than 31% of the PD populations in Connecticut, Pennsylvania, Hawaii, and Rhode Island were aged 85+. PD patients who were "dual-eligible"-receiving both Medicare and Medicaid benefits-also varied by state, from <10% to >25%. Hospitalizations varied from 304 to 653 stays per 1000 PD patients and accounted for 26.5% of the 7.9 billion United States Dollars (USD) paid by the Medicare program for healthcare services delivered to our sample. A diagnosis of PD was associated with greater healthcare use and spending. This study provides initial evidence of substantial geographic variation in PD patient characteristics, health service use, and spending. Further study is necessary to inform the development of state- and federal-level health policies that are cost-efficient and support desired outcomes for PD patients.

dc.identifier

74

dc.identifier.issn

2373-8057

dc.identifier.issn

2373-8057

dc.identifier.uri

https://hdl.handle.net/10161/19049

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

NPJ Parkinson's disease

dc.relation.isversionof

10.1038/s41531-019-0074-8

dc.title

State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.

dc.type

Journal article

duke.contributor.orcid

Mantri, Sneha|0000-0003-4556-0522

pubs.begin-page

1

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Neurology, Movement Disorders

pubs.organisational-group

Neurology

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.pdf
Size:
1.89 MB
Format:
Adobe Portable Document Format
Description:
Published version